Bright-light exposure and exercise program for cancer patients
Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program on Sleep-Wake Rhythm, Physical and Psychological Symptoms, and Quality of Life of Patients With Thoracic Cancer: A Series Study.
This study is testing if a six-week program that combines bright-light exposure with exercise can help people with lung and esophageal cancer feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Taipei Veterans General Hospital, Taiwan Government |
| Locations | 2 sites (Taipei City, Taipei and 1 other locations) |
| Trial ID | NCT05875870 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a six-week program combining bright-light exposure with exercise training for patients diagnosed with lung and esophageal cancer. Participants will be randomly assigned to either the experimental group, which receives the intervention, or an active control group that performs stretching exercises. The study aims to assess improvements in sleep-wake rhythm, physical and mental symptoms, quality of life, and long-term outcomes such as recurrence and survival rates. Data will be collected at multiple time points over a year to evaluate the program's impact.
Who should consider this trial
Good fit: Ideal candidates include adults aged 20 and older with newly diagnosed lung or esophageal cancer at stages one to three.
Not a fit: Patients with congestive heart failure or orthopedic diseases that limit walking ability may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly enhance the quality of life and survival rates for patients with lung and esophageal cancer.
How similar studies have performed: Other studies have shown promising results with light exposure and exercise interventions in cancer care, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with newly diagnosed primary lung cancer or esophageal cancer, from the first stage to the third stage. 2. At least 20 years of age. 3. Able to communicate in Mandarin Chinese or Taiwanese. 4. Literate and free from cognitive disabilities. 5. The attending physician agrees to participate in the study. 6. Those who can connect to the Internet with mobile devices such as computers, mobile phones, and tablets, or those whose family members can assist in the operation. 7. Those with Karnofsky Performance Scale (KPS) greater than or equal to 70 points. 8. Those who are hospitalized for lung cancer or esophageal cancer lesion resection. Exclusion Criteria: 1. Congestive heart failure. 2. Orthopedic diseases of the lower extremities that limit one's walking ability.
Where this trial is running
Taipei City, Taipei and 1 other locations
- Taipei Veterans General Hospital — Taipei City, Taipei, Taiwan (Recruiting)
- Taipei Medical University Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Principal investigator: Hui-Mei Chen, PhD — National Taipei University of Nursing and Health Sciences
- Study coordinator: Hui-Mei Chen, PhD
- Email: alice@ntunhs.edu.tw
- Phone: 886-2-28227101
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.